9 medical device stocks to watch

The best medical device stocks depend on your portfolio and investment goals—while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

9 popular medical device stocks to watch

We round up a selection of stocks in or related to the health product industry, weighting the list more heavily towards popular mid- and large-cap stocks.

1. Abbott Laboratories (ABT)
2. ABIOMED (ABMD)
3. Align Technology (ALGN)
4. Edwards Lifesciences (EW)
5. Boston Scientific (BSX)
6. Medtronic (MDT)
7. Penumbra (PEN)
8. Inogen (INGN)
9. SmileDirectClub (SDC)

Compare investment accounts that help you research stocks

The medical device stocks industry is affected by a range of complex factors such as trade policies, regulations, and fluctuating supply and demand. So when considering medical device stocks to buy, it's important that you have access to vital information about a company's financial health, leadership team, and market positioning.

Our picks for platforms with research tools

How to invest in medical device stocks

1. Choose an online stock trading platform. Choose from our Top Picks above, use our comparison table below or jump straight to the best stock trading apps in Canada.
2. Sign up for an account. Provide your personal information and sign up.
3. Set up a funding method to pay for the transaction. Deposit funds into your account by linking your banking information.
4. Choose the stocks you want to buy. Search for the stock by name or ticker symbol like ABT or ABMD.
5. Place your order. Buy the stock. It's that simple.

Learn more about popular medical device stocks

We round up a selection of stocks in or related to the health product industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

---

1. Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

• Previous close price: $132.82
• Market capitalization: $225,571,307,520
• 1 year performance: 24.96%
• P/E ratio: 16.9542

Buy ABT stock on Interactive Brokers

---

2. ABIOMED (ABMD)

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients.

• Previous close price: $0.00
• Market capitalization: $17,180,649,472
• 1 year performance: N/A
• P/E ratio: 65.3551

Buy ABMD stock on Interactive Brokers

---

3. Align Technology (ALGN)

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years with a mixture of primary/baby and permanent teeth.

• Previous close price: $179.82
• Market capitalization: $12,939,189,248
• 1 year performance: -41.81%
• P/E ratio: 32.1931

Buy ALGN stock on Interactive Brokers

---

4. Edwards Lifesciences (EW)

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve.

• Previous close price: $75.65
• Market capitalization: $44,247,932,928
• 1 year performance: -12.47%
• P/E ratio: 31.7395

Buy EW stock on Interactive Brokers

---

5. Boston Scientific (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems.

• Previous close price: $104.93
• Market capitalization: $155,198,816,256
• 1 year performance: 43.41%
• P/E ratio: 76.5912

Buy BSX stock on Interactive Brokers

---

6. Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products.

• Previous close price: $84.85
• Market capitalization: $107,169,038,336
• 1 year performance: 6.41%
• P/E ratio: 25.4756

Buy MDT stock on Interactive Brokers

---

7. Penumbra (PEN)

Penumbra, Inc. , together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

• Previous close price: $296.00
• Market capitalization: $11,462,865,920
• 1 year performance: 44.81%
• P/E ratio: 276.6355

Buy PEN stock on Interactive Brokers

---

8. Inogen (INGN)

Inogen, Inc. , a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

• Previous close price: $7.20
• Market capitalization: $193,587,840
• 1 year performance: 6.19%

Buy INGN stock on Interactive Brokers

---

9. SmileDirectClub (SDC)

SmileDirectClub, Inc. , an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria.

• Previous close price: $0.00
• Market capitalization: $29,108,252
• 1 year performance: N/A

Buy SDC stock on Interactive Brokers

Buy medical device stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Bottom line

While it's possible to turn a profit investing in medical device stocks, keep in mind that—like any investment—medical device stocks are not immune to risk. These stocks are subject to fluctuating conditions both in the market and in the health product industry, so carefully vet your picks before you invest. If you're new to investing or if it's been a while since you've taken a critical look at your investment accounts, compare brokers to make sure you're getting the best trading features for your needs.

Related: How to buy stocks in Canada

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.